Disclosed are compounds which inhibit histone deacetylase (HDAC) enzymatic activity. Also disclosed are pharmaceutical compositions comprising such compounds as well as methods to treat conditions, particularly proliferative conditions, mediated at least in part by HDAC.

 
Web www.patentalert.com

< Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease

> Histone deacetylase inhibitors

~ 00419